L

LYFE Capital

31 employees

LYFE Capital is a life science investment firm.

Investor insights

Sectors invested in

Biotechnology23
Health Care23
Medical9
Pharmaceutical6
Therapeutics6
Manufacturing5
Medical Device5
Cell Therapy4
Life Science3
Genetics3
Robotics2
Adjuvant2
Vaccine2
COVID19 Vaccine2
HPV Vaccine2
Diagnostics2
DNA Data Storage2
Genetic Medicines2
Vaccines2
DNA Synthesis2

Funding rounds participated in

$43M sweet spot round size

Most of their 52 investments are in rounds between $22M and $70M

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology
Private Equity
Healthcare industry
Diagnostics
United States
China
Life science
Pharmaceutical
Medical Devices
Venture Capital

Date founded

2015

Investments made

U

Undisclosed raised $41M on August 28, 2023

Investors: Guotai Junan Securities Co., Ltd, Legend Capital, Lake Bleu Capital (Hong Kong) Limited and LYFE Capital

N

Noah Medical raised $150M on April 19, 2023

Investors: UpHonest Capital, ShangBay Capital, AME Cloud Ventures, Prosperity7 Ventures, 1955 Capital, Sequoia Capital China, SoftBank Investment Advisers and LYFE Capital

基点生物科技(上海)有限公司 raised $29M on January 19, 2023

Investors: 厦门德屹股权投资管理有限公司 and LYFE Capital

U

Undisclosed raised $13M on December 22, 2022

Investors: LYFE Capital

i

iECURE, inc. raised $65M on November 30, 2022

Investors: Versant Ventures, OrbiMed Advisors, Novo Holdings and LYFE Capital

U

Undisclosed raised $1.4M on October 25, 2022

Investors: 上海涌铧投资管理有限公司 and LYFE Capital

I

ICE Biotechnology Pte. Ltd. raised $14M on September 26, 2022

Investors: 毅达资本 and LYFE Capital

U

Undisclosed raised $13M on July 25, 2022

Investors: LYFE Capital

P

ProfoundBio raised $70M on June 2, 2022

Investors: Lilly Asia Ventures, Sequoia Capital China, K2VC 险峰 and LYFE Capital

S

Starna Therapeutics raised $22M on May 16, 2022

Investors: Hillhouse Capital Management, Hony Capital, Primavera Capital Group 春华资本集团 and LYFE Capital

FAQ